{"id":2047,"date":"2018-09-15T11:03:21","date_gmt":"2018-09-15T11:03:21","guid":{"rendered":"http:\/\/lyl-biotic.com018\/09\/15\/saccharomyces-boulardii-reduce-risk-of-diarrhea-when-travelling-or-beginning-kindergarten\/"},"modified":"2018-09-18T19:03:38","modified_gmt":"2018-09-18T19:03:38","slug":"saccharomyces-boulardii-reduce-risk-of-diarrhea-when-travelling-or-beginning-kindergarten","status":"publish","type":"post","link":"https:\/\/lyl-biotic.com\/lv\/saccharomyces-boulardii-reduce-risk-of-diarrhea-when-travelling-or-beginning-kindergarten\/","title":{"rendered":"Saccharomyces boulardii mazina risku piedz\u012bvot caureju ce\u013cojum\u0101 vai uzs\u0101kot b\u0113rnud\u0101rza gaitas"},"content":{"rendered":"
Ce\u013cot\u0101ju caurejai rakstur\u012bga caureja vai aizciet\u0113jums, v\u0113ders\u0101pes un citi ku\u0146\u0123a \u2013 zarnu trakta trauc\u0113jumi, kurus piedz\u012bvo, kad non\u0101kot kaut kur \u0101rpus sev ierast\u0101s vides \u201esve\u0161o bakt\u0113riju\u201d ielenkum\u0101. Ce\u013cot\u0101ju caureju piedz\u012bvo no 5% l\u012bdz 50% cilv\u0113ku, atkar\u012bb\u0101 no ce\u013cojuma galam\u0113r\u0137a.<\/h6>\n
\n
\n
Probiotikas ir daudzsolo\u0161as ce\u013cot\u0101ju caurejas profilaks\u0113, liecina apkopojums par 12 dubultakliem, placebo-kontrol\u0113tiem p\u0113t\u012bjumiem. Iev\u0113rojami efekt\u012bvas ir Saccharomyces boulardii un divu probiotisko bakt\u0113riju Lactobacillus acidophilus un Bifidobacterium bifidum mais\u012bjums. [1] Ce\u013cot\u0101ju caureja S. Boulardi lietot\u0101ju grup\u0101 vid\u0113ji abos p\u0113t\u012bjumos sv\u0101rst\u012bj\u0101s no 5% – 11%. [2] [3]<\/h6>\n
Kollaritsch et al ir veicis l\u012bdz \u0161im visapjom\u012bg\u0101kos p\u0113t\u012bjumus par Saccharomyces boulardii labv\u0113l\u012bgo ietekmi uz ce\u013cot\u0101ju caureju. Galvenais secin\u0101jums \u2013 probiotikas ir efekt\u012bvs profilaktisks l\u012bdzeklis. Ja lietotas aptuveni ned\u0113\u013cu pirms ce\u013cojuma, tas var mazin\u0101t iesp\u0113ju saslimt ar ce\u013cot\u0101ju caureju. Vien\u0101 no p\u0113t\u012bjumiem tika nov\u0113roti 1231 Austrijas t\u016bristi, kas dev\u0101s ce\u013cojum\u0101 uz siltaj\u0101m zem\u0113m. Tie 3 ned\u0113\u013cas lietoja k\u0101du no S.boulardii dev\u0101m (250 vai 500 mg) vai placebo. Ce\u013cot\u0101ji uzs\u0101ka probiotiku kursu 5 dienas pirms ce\u013cojuma un turpin\u0101j\u0101s visu ce\u013cojuma laiku. Ce\u013cot\u0101ju caureju pieredz\u0113ja 43% placebo grup\u0101, turpretim b\u016btiski maz\u0101k 250 mg (34%) un 500 mg (32%) S.boulardii grup\u0101.[2]\u00a0 Otr\u0101 Kollaritsch et al<\/em> p\u0113t\u012bjum\u0101, 1016 austrie\u0161i, kuri dev\u0101s uz Zieme\u013c\u0101friku, Vid\u0113jiem austrumiem un T\u0101lajiem Austrumiem, tika noz\u012bm\u0113tas\u00a0 250 mg\/d (5 \u00d7 109<\/sup>)\u00a0S. boulardii, 1000 mg\/d (2 \u00d7 1010<\/sup>)\u00a0S. boulardii\u00a0vai placebo, kuras uzs\u0101ka lietot 5 dienas pirms do\u0161an\u0101s ce\u013c\u0101. S.boulardii b\u016btiski mazin\u0101ja ar ce\u013cot\u0101ju caureju saslimu\u0161o t\u016brsitu skaitu.\u00a0 39% placebo grup\u0101, bet tikai 34% 250 mg S. Boulardii grup\u0101 un 29% 500 mg S. Boulardii grup\u0101 pieredz\u0113ja ce\u013cot\u0101ju caureju\u00a0 (P<\/em>\u00a0< 0.05).[3]<\/h6>\n<\/div>\n<\/div>\n
    \n
  1. McFarland LV. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med Infect Dis.\u00a02007 Mar;5(2):97-105. Epub 2005 Dec 5.<\/li>\n
  2. Kollaritsch H, Kremsner P, Wiedermann , G , Scheiner O. Prevention of traveller\u2019s diarrhea: comparison of different non-antibiotic preparations.\u00a0Travel Med Internatl.\u00a01989;7:9\u201318.<\/li>\n
  3. Kollaritsch H, Holst H, Grobara P, Wiedermann G. [Prevention of traveler’s diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study]\u00a0Fortschr Med.\u00a01993;111:152\u2013156<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Ce\u013cot\u0101ju caurejai rakstur\u012bga caureja vai aizciet\u0113jums, v\u0113ders\u0101pes un citi ku\u0146\u0123a \u2013 zarnu trakta trauc\u0113jumi, kurus piedz\u012bvo, kad non\u0101kot kaut kur \u0101rpus sev ierast\u0101s vides \u201esve\u0161o bakt\u0113riju\u201d ielenkum\u0101. Ce\u013cot\u0101ju caureju piedz\u012bvo no 5% l\u012bdz 50% cilv\u0113ku, atkar\u012bb\u0101 no ce\u013cojuma galam\u0113r\u0137a. Probiotikas ir daudzsolo\u0161as ce\u013cot\u0101ju caurejas profilaks\u0113, liecina apkopojums par 12 dubultakliem, placebo-kontrol\u0113tiem p\u0113t\u012bjumiem. Iev\u0113rojami efekt\u012bvas ir […]<\/p>\n","protected":false},"author":1,"featured_media":1890,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[44],"tags":[],"_links":{"self":[{"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/posts\/2047\/"}],"collection":[{"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/posts\/"}],"about":[{"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/types\/post\/"}],"author":[{"embeddable":true,"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/users\/1\/"}],"replies":[{"embeddable":true,"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/comments\/?post=2047"}],"version-history":[{"count":1,"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/posts\/2047\/revisions\/"}],"predecessor-version":[{"id":2048,"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/posts\/2047\/revisions\/2048\/"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/media\/1890\/"}],"wp:attachment":[{"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/media\/?parent=2047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/categories\/?post=2047"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lyl-biotic.com\/lv\/wp-json\/wp\/v2\/tags\/?post=2047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}